ACAD
ACADIA Pharmaceuticals Inc
NASDAQ: ACAD · HEALTHCARE · BIOTECHNOLOGY
$27.83
+0.32% today
Updated 2026-09-11
Market cap
$4.77B
P/E ratio
12.36
P/S ratio
4.19x
EPS (TTM)
$2.24
Dividend yield
—
52W range
$20 – $31
Volume
1.6M
ACADIA Pharmaceuticals Inc (ACAD) Financial Forecast & Price Target 2030
Revenue-driven projection model with historical context.
Price target summary
Current price
$27.83
12-Month target
$21.13
2030 Target
—
Intrinsic (DCF)
—
Financial forecast
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $0.5B | $0.5B | $0.7B | $1.0B | $1.1B |
| EPS | — | — | — | — | — |
CAGR applied: — (capped 20%) · P/E: 12.36x (capped 25x) · Margin: 33.40%
Methodology
CAGR-based projection model. Research-backed estimates are being generated — check back soon for analyst consensus and management guidance.